about
Validation of the Rheumatoid and Arthritis Outcome Score (RAOS) for the lower extremitySix-week high-intensity exercise program for middle-aged patients with knee osteoarthritis: a randomized controlled trial [ISRCTN20244858]Development of patient-centred standards of care for osteoarthritis in Europe: the eumusc.net-projectSickness absence from work among persons with new physician-diagnosed carpal tunnel syndrome: a population-based matched-cohort studySmoking is associated with a worse self-reported health status in patients with psoriatic arthritis: data from a Swedish population-based cohort.Performance in physical education and health impairment 30 years later--a community based cohort studySerum levels of cartilage oligomeric matrix protein (COMP) increase temporarily after physical exercise in patients with knee osteoarthritisRapid and sustained health utility gain in anti-tumour necrosis factor-treated inflammatory arthritis: observational data during 7 years in southern Sweden.Muscle strength in adolescent men and risk of cardiovascular disease events and mortality in middle age: a prospective cohort studyValidity of diagnostic codes and prevalence of physician-diagnosed psoriasis and psoriatic arthritis in southern Sweden--a population-based register study.Sick leave patterns in common musculoskeletal disorders--a study of doctor prescribed sick leave.Sickness absence in musculoskeletal disorders - patients' experiences of interactions with the social insurance agency and health care. A qualitative studyThe risk for depression in patients with ankylosing spondylitis: a population-based cohort study.Population-based consultation patterns in patients with shoulder pain diagnosesInternational comparisons of the consultation prevalence of musculoskeletal conditions using population-based healthcare data from England and SwedenPromoting work ability in a structured national rehabilitation program in patients with musculoskeletal disorders: outcomes and predictors in a prospective cohort study.Osteoarthritis of the peripheral joints.Decrease in the incidence of total hip arthroplasties in patients with rheumatoid arthritis--results from a well defined population in south Sweden.Cartilage markers in synovial fluid in symptomatic knee osteoarthritis.Correlation between radiographically diagnosed osteophytes and magnetic resonance detected cartilage defects in the patellofemoral joint.Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern Sweden.Predictors of patient relevant outcome after total hip replacement for osteoarthritis: a prospective study.Reduced functional performance in the lower extremity predicted radiographic knee osteoarthritis five years later.A randomised placebo controlled 12 week trial of budesonide and prednisolone in rheumatoid arthritisCost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched randomised controlled SWEFOT trial.The association between antibody levels before and after 7-valent pneumococcal conjugate vaccine immunization and subsequent pneumococcal infection in chronic arthritis patients.Smoking is a strong risk factor for rheumatoid nodules in early rheumatoid arthritis.Diurnal variation in serum levels of cartilage oligomeric matrix protein in patients with knee osteoarthritis or rheumatoid arthritis.Back pain and health status in patients with clinically diagnosed ankylosing spondylitis, psoriatic arthritis and other spondyloarthritis: a cross-sectional population-based study.Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis.Evolution of team care and evaluation of effectiveness.Referring to multimodal rehabilitation for patients with musculoskeletal disorders - a register study in primary health care.Comparison of the Swedish STarT Back Screening Tool and the Short Form of the Örebro Musculoskeletal Pain Screening Questionnaire in patients with acute or subacute back and neck pain.Income disparities in healthcare use remain after controlling for healthcare need: evidence from Swedish register data on psoriasis and psoriatic arthritis.Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients--baseline characteristics, treatment adherence, and development of clinical variables during three years of anti-TNF therapy in clinical practice.Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial.Muscle strength in adolescent men and future musculoskeletal pain: a cohort study with 17 years of follow-upPatients with ankylosing spondylitis have increased sick leave--a registry-based case-control study over 7 yrs.Development of patient-centred standards of care for rheumatoid arthritis in Europe: the eumusc.net projectSick leave in Sweden before and after total joint replacement in hip and knee osteoarthritis patients.
P50
Q24798133-74C8B881-A317-40CD-A604-609919BB781FQ24813826-831F66A6-886F-4EE1-AE2B-8719862B96C0Q26998214-45A19E45-457E-4498-9A1C-1CEA07EBDBFBQ28390429-99E57982-C02D-4246-A2AF-0978B366FE40Q30836524-AAAC8D83-25F3-4A54-B03C-01D350696A8DQ31060314-97884EC0-981D-40D5-9DA8-36E183FD5E53Q33265934-91B46A07-9540-46C7-8171-7F46B6A78B90Q33417529-BC3D9A51-DB29-4DFC-9E67-179CEC38F1E0Q33552590-D1B9592A-6028-44A6-A14B-16F13E93CD4AQ33685731-D70F7804-A545-4D8B-99FD-F756CA2B02F7Q33767877-1604FF40-CB83-4ADF-A4BF-C33A5834E618Q33821500-9A216038-A60A-4F7B-8DBA-457FCAEB020CQ34267367-A98AE637-3DEB-462A-ACB7-C73466B088F1Q34494761-6ACC6B1A-BBEA-404F-AA60-6BA01C4E67AAQ34560536-B0B490D7-9B02-4B9E-BEC4-179A254FEB56Q34577667-DD3B8A99-F8CA-47C9-900C-B2D97D21D472Q35021048-9881ADCC-532A-44BF-822C-BABDC1B8F311Q35093040-C42B844F-7C7E-4973-A463-69AE32F2342BQ35546913-1EA8FC8B-4EFB-41D5-A08A-178CDA55E7E0Q35548007-AA095BAC-38EF-45E1-8A8B-ED789AB9A1D7Q35551908-EDD68DF3-AD6B-45DF-8DD8-9728F7D38217Q35552077-743472E5-7662-495C-9329-3F20AE89957FQ35554013-46BFA44C-E7F7-452D-8927-11730C2D02A5Q35554167-5E11CF86-7E7F-4696-AB56-BD614EDB3B62Q35605415-7A8E5078-BE4B-4245-A44C-70B82CBAC79FQ35622117-0DB2FBD2-B284-489A-93C4-49BAFED5D678Q35637122-44B59FE8-FDAB-42C9-8F4B-9892D3B6718AQ35638162-862837C7-43DB-4CC1-A80A-D67CD3670B04Q35938403-2D5804C4-2739-4E8E-AD07-4C56BC4BC7C3Q35953268-ED9FAC72-711F-4F45-AB05-345ED889FD59Q36042043-27595885-A088-4DE0-A787-2EDF9612213CQ36243344-1DDD59B2-4C4D-4F1A-AAEF-5FCF6CBEC829Q36286760-C3B836B3-AF62-4521-973D-52DD4A606887Q36376868-26201FB6-332A-498C-97FE-F46465DA7F14Q36477447-61D4DFEF-9CBF-4916-865C-090FC8EBFCC6Q36577396-0591E103-DECE-4317-85AB-66E0C31D1875Q36889461-EB39A737-0658-4C4E-BB40-D5958B739680Q37100632-B0EF99BC-4EAD-4E12-B98C-E2FBBA946AF3Q37715952-8C7E61FB-409E-4EB7-A7CF-44A7D06D512FQ37742512-89826935-146D-4DE3-A0AE-6964D8ECF2CA
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ingemar F Petersson
@nl
Ingemar F Petersson
@sl
Ingemar F. Petersson
@en
Ingemar F. Petersson
@es
type
label
Ingemar F Petersson
@nl
Ingemar F Petersson
@sl
Ingemar F. Petersson
@en
Ingemar F. Petersson
@es
altLabel
Ingemar F Petersson
@en
prefLabel
Ingemar F Petersson
@nl
Ingemar F Petersson
@sl
Ingemar F. Petersson
@en
Ingemar F. Petersson
@es
P106
P1153
7003466910
P21
P31
P496
0000-0001-9139-1892